Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is a 50% decrease from the number of companies cited in the previous quarter.
The citations in the county include:
- Your plant did not have adequate sanitary facilities and accommodations.
- You did not implement your allergen monitoring procedures.
- Your written process corrective action and verification procedures were not appropriate to significantly minimize or prevent the hazard requiring a preventive control.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Gate Gourmet #301 | Food and Cosmetics | 02/28/2024 | Sanitary facilities and controls |
| Gate Gourmet #301 | Food and Cosmetics | 02/28/2024 | Allergen preventive controls - Implement |
| Gate Gourmet #301 | Food and Cosmetics | 02/28/2024 | Process preventive controls - Appropriate (Adequate) |
| Gate Gourmet #301 | Food and Cosmetics | 02/28/2024 | Supply-chain program - Assurance (Adequate) |
Alerts Sign-up